418 related articles for article (PubMed ID: 15769853)
1. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
Henriksen U; Gether U; Litman T
J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
[TBL] [Abstract][Full Text] [Related]
2. Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
Ozvegy C; Váradi A; Sarkadi B
J Biol Chem; 2002 Dec; 277(50):47980-90. PubMed ID: 12374800
[TBL] [Abstract][Full Text] [Related]
3. Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers.
Bhatia A; Schäfer HJ; Hrycyna CA
Biochemistry; 2005 Aug; 44(32):10893-904. PubMed ID: 16086592
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
5. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
6. Effects of putative catalytic base mutation E211Q on ABCG2-mediated methotrexate transport.
Hou YX; Li CZ; Palaniyandi K; Magtibay PM; Homolya L; Sarkadi B; Chang XB
Biochemistry; 2009 Sep; 48(38):9122-31. PubMed ID: 19691360
[TBL] [Abstract][Full Text] [Related]
7. Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
Ozvegy-Laczka C; Várady G; Köblös G; Ujhelly O; Cervenak J; Schuetz JD; Sorrentino BP; Koomen GJ; Váradi A; Német K; Sarkadi B
J Biol Chem; 2005 Feb; 280(6):4219-27. PubMed ID: 15557326
[TBL] [Abstract][Full Text] [Related]
8. Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.
Henriksen U; Fog JU; Litman T; Gether U
J Biol Chem; 2005 Nov; 280(44):36926-34. PubMed ID: 16107343
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
Ozvegy C; Litman T; Szakács G; Nagy Z; Bates S; Váradi A; Sarkadi B
Biochem Biophys Res Commun; 2001 Jul; 285(1):111-7. PubMed ID: 11437380
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis.
Jha S; Karnani N; Dhar SK; Mukhopadhayay K; Shukla S; Saini P; Mukhopadhayay G; Prasad R
Biochemistry; 2003 Sep; 42(36):10822-32. PubMed ID: 12962507
[TBL] [Abstract][Full Text] [Related]
11. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).
Robey RW; Honjo Y; van de Laar A; Miyake K; Regis JT; Litman T; Bates SE
Biochim Biophys Acta; 2001 Jun; 1512(2):171-82. PubMed ID: 11406094
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
13. Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.
Cai X; Bikadi Z; Ni Z; Lee EW; Wang H; Rosenberg MF; Mao Q
J Pharmacol Exp Ther; 2010 Jun; 333(3):670-81. PubMed ID: 20203106
[TBL] [Abstract][Full Text] [Related]
14. The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate binding.
Ejendal KF; Diop NK; Schweiger LC; Hrycyna CA
Protein Sci; 2006 Jul; 15(7):1597-607. PubMed ID: 16815914
[TBL] [Abstract][Full Text] [Related]
15. Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.
Ozvegy-Laczka C; Köblös G; Sarkadi B; Váradi A
Biochim Biophys Acta; 2005 Feb; 1668(1):53-63. PubMed ID: 15670731
[TBL] [Abstract][Full Text] [Related]
16. The linker region of breast cancer resistance protein ABCG2 is critical for coupling of ATP-dependent drug transport.
Macalou S; Robey RW; Jabor Gozzi G; Shukla S; Grosjean I; Hegedus T; Ambudkar SV; Bates SE; Di Pietro A
Cell Mol Life Sci; 2016 May; 73(9):1927-37. PubMed ID: 26708291
[TBL] [Abstract][Full Text] [Related]
17. Identification of proline residues in or near the transmembrane helices of the human breast cancer resistance protein (BCRP/ABCG2) that are important for transport activity and substrate specificity.
Ni Z; Bikadi Z; Shuster DL; Zhao C; Rosenberg MF; Mao Q
Biochemistry; 2011 Sep; 50(37):8057-66. PubMed ID: 21854076
[TBL] [Abstract][Full Text] [Related]
18. The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2.
Shukla S; Robey RW; Bates SE; Ambudkar SV
Biochemistry; 2006 Jul; 45(29):8940-51. PubMed ID: 16846237
[TBL] [Abstract][Full Text] [Related]
19. Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activity.
Xu J; Peng H; Chen Q; Liu Y; Dong Z; Zhang JT
Cancer Res; 2007 May; 67(9):4373-81. PubMed ID: 17483351
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
